Comparison of the Efficacy and Safety of Different Doses of Linaclotide for Patients with Chronic Constipation: A Meta-Analysis and Bayesian Analysis

<div>Probability rank of CSBM responders (a) and any AEs (b) by Bayesian analysis. A, B, C, D, and E were the extremely low-dose group, low-dose group, medium-dose group, high-dose group, and placebo group, respectively.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Comparison of the Efficacy and Safety of Different Doses of Linaclotide for Patients with Chronic Constipation: A Meta-Analysis and Bayesian Analysis 

Figure 4 | Comparison of the Efficacy and Safety of Different Doses of Linaclotide for Patients with Chronic Constipation: A Meta-Analysis and Bayesian Analysis 